The Zacks Analyst Blog Highlights: ResMed, Invacare, Fresenius, Henry Schein and Quest Diagnostics
The developments are expected to strengthen Henry Schein's (HSIC) presence in high potential and still-untapped markets.
Henry Schein, Inc. acquires majority interest in Prism Medical Products and enters the home medical supply market.